Nikolas von Bubnoff

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 42

Top Topics

Acute Myeloid Leukemia

Tyrosine Kinase

Liver Metastases

Stem Cell Transplantation

Top Venues

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Johannes Lübke, Alicia Schmid, Deborah Christen, Joanne N G Oude Elberink, Lambert F R Span, Marek Niedoszytko, Aleksandra Gorska, Magdalena Lange, Karoline V Gleixner, Emir Hadzijusufovic, Alex Stefan, Irena Angelova-Fischer, Roberta Zanotti, Massimiliano Bonifacio, Patrizia Bonadonna, Khalid Shoumariyeh, Nikolas von Bubnoff, Sabine Müller, Cecelia Perkins, Chiara Elena, Luca Malcovati, Hans Hagglund, Mattias Mattsson, Roberta Parente, Judit Varkonyi, Anna Belloni Fortina, Francesca Caroppo, Knut Brockow, Alexander Zink, Christine Breynaert, Toon Leven, Akif Selim Yavuz, Michael Doubek, Vito Sabato, Tanja Schug, Karin Hartmann, Massimo Triggiani, Jason Gotlib, Olivier Hermine, Michel Arock, Hanneke C Kluin-Nelemans, Jens Peter Panse, Wolfgang R Sperr, Peter Valent, Andreas Reiter, Juliana Schwaab
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM. Blood advances 8 (11) (2024)
Lennart von Fritsch, Nikolas von Bubnoff, Klaus Weber, Jutta Kirfel, Cleopatra Schreiber, Tobias Keck, Ulrich Wellner
Near complete remission of an inoperable pancreatic acinar cell carcinoma after BRAF-/MEK-inhibitor treatment-A case report and review of the literature. Genes, chromosomes & cancer 63 (2) (2024)
Lennart von Fritsch, Nikolas von Bubnoff, Klaus Weber, Jutta Kirfel, Cleopatra Schreiber, Tobias Keck, Ulrich Wellner
Near complete remission of an inoperable pancreatic acinar cell carcinoma after BRAF-/MEK-inhibitor treatment-A case report and review of the literature. Genes, chromosomes & cancer 63 (2) (2024)
Max Kappenstein, Nikolas von Bubnoff
Real-World Electronic Medical Records Data Identify Risk Factors for Myelofibrosis and Can Be Used to Validate Established Prognostic Scores. Cancers 16 (7) (2024)
Svenja Denker, Axel Künstner, Julian Schwarting, Hanno M Witte, Veronica Bernard, Stephanie Stölting, Philipp Lohneis, Kathrin Kusch, Nikolas von Bubnoff, Hartmut Merz, Hauke Busch, Alfred C Feller, Niklas Gebauer
Clonal evolution and blastic plasmacytoid dendritic cell neoplasm: malignancies of divergent hematopoietic lineages emerging from a common founding clone. Leukemia 38 (8) (2024)
Max Kappenstein, Nikolas von Bubnoff
Real-World Electronic Medical Records Data Identify Risk Factors for Myelofibrosis and Can Be Used to Validate Established Prognostic Scores. Cancers 16 (7) (2024)
Max Kappenstein, Nikolas von Bubnoff
Real-World Electronic Medical Records Data Identify Risk Factors for Myelofibrosis and Can Be Used to Validate Established Prognostic Scores. Cancers 16 (7) (2024)
Svenja Denker, Axel Künstner, Julian Schwarting, Hanno M Witte, Veronica Bernard, Stephanie Stölting, Philipp Lohneis, Kathrin Kusch, Nikolas von Bubnoff, Hartmut Merz, Hauke Busch, Alfred C Feller, Niklas Gebauer
Clonal evolution and blastic plasmacytoid dendritic cell neoplasm: malignancies of divergent hematopoietic lineages emerging from a common founding clone. Leukemia 38 (8) (2024)
Johannes Lübke, Alicia Schmid, Deborah Christen, Joanne N G Oude Elberink, Lambert F R Span, Marek Niedoszytko, Aleksandra Gorska, Magdalena Lange, Karoline V Gleixner, Emir Hadzijusufovic, Alex Stefan, Irena Angelova-Fischer, Roberta Zanotti, Massimiliano Bonifacio, Patrizia Bonadonna, Khalid Shoumariyeh, Nikolas von Bubnoff, Sabine Müller, Cecelia Perkins, Chiara Elena, Luca Malcovati, Hans Hagglund, Mattias Mattsson, Roberta Parente, Judit Varkonyi, Anna Belloni Fortina, Francesca Caroppo, Knut Brockow, Alexander Zink, Christine Breynaert, Toon Leven, Akif Selim Yavuz, Michael Doubek, Vito Sabato, Tanja Schug, Karin Hartmann, Massimo Triggiani, Jason Gotlib, Olivier Hermine, Michel Arock, Hanneke C Kluin-Nelemans, Jens Peter Panse, Wolfgang R Sperr, Peter Valent, Andreas Reiter, Juliana Schwaab
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM. Blood advances 8 (11) (2024)
Johannes Lübke, Alicia Schmid, Deborah Christen, Joanne N G Oude Elberink, Lambert F R Span, Marek Niedoszytko, Aleksandra Górska, Magdalena Lange, Karoline V Gleixner, Emir Hadzijusufovic, Alex Stefan, Irena Angelova-Fischer, Roberta Zanotti, Massimiliano Bonifacio, Patrizia Bonadonna, Khalid Shoumariyeh, Nikolas von Bubnoff, Sabine Müller, Cecelia Perkins, Chiara Elena, Luca Malcovati, Hans G Hagglund, Mattias Mattsson, Roberta Parente, Judit Varkonyi, Anna Belloni Fortina, Francesca Caroppo, Knut Brockow, Alexander Zink, Christine Breynaert, Toon Ieven, Akif Selim Yavuz, Michael Doubek, Vito Sabato, Tanja Schug, Karin Hartmann, Massimo Triggiani, Jason Gotlib, Olivier Hermine, Michel Arock, Hanneke C Kluin-Nelemans, Jens Peter Panse, Wolfgang R Sperr, Peter Valent, Andreas Reiter, Juliana Schwaab
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM. Blood advances (2024)
Lennart von Fritsch, Nikolas von Bubnoff, Klaus Weber, Jutta Kirfel, Cleopatra Schreiber, Tobias Keck, Ulrich Wellner
Near complete remission of an inoperable pancreatic acinar cell carcinoma after BRAF-/MEK-inhibitor treatment-A case report and review of the literature. Genes, chromosomes & cancer 63 (2) (2024)
Johannes Lübke, Alicia Schmid, Deborah Christen, Joanne N G Oude Elberink, Lambert F R Span, Marek Niedoszytko, Aleksandra Gorska, Magdalena Lange, Karoline V Gleixner, Emir Hadzijusufovic, Alex Stefan, Irena Angelova-Fischer, Roberta Zanotti, Massimiliano Bonifacio, Patrizia Bonadonna, Khalid Shoumariyeh, Nikolas von Bubnoff, Sabine Müller, Cecelia Perkins, Chiara Elena, Luca Malcovati, Hans Hagglund, Mattias Mattsson, Roberta Parente, Judit Varkonyi, Anna Belloni Fortina, Francesca Caroppo, Knut Brockow, Alexander Zink, Christine Breynaert, Toon Leven, Akif Selim Yavuz, Michael Doubek, Vito Sabato, Tanja Schug, Karin Hartmann, Massimo Triggiani, Jason Gotlib, Olivier Hermine, Michel Arock, Hanneke C Kluin-Nelemans, Jens Peter Panse, Wolfgang R Sperr, Peter Valent, Andreas Reiter, Juliana Schwaab
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM. Blood advances 8 (11) (2024)
Svenja Denker, Axel Künstner, Julian Schwarting, Hanno M Witte, Veronica Bernard, Stephanie Stölting, Philipp Lohneis, Kathrin Kusch, Nikolas von Bubnoff, Hartmut Merz, Hauke Busch, Alfred C Feller, Niklas Gebauer
Clonal evolution and blastic plasmacytoid dendritic cell neoplasm: malignancies of divergent hematopoietic lineages emerging from a common founding clone. Leukemia (2024)
Svenja Denker, Axel Künstner, Julian Schwarting, Hanno M Witte, Veronica Bernard, Stephanie Stölting, Philipp Lohneis, Kathrin Kusch, Nikolas von Bubnoff, Hartmut Merz, Hauke Busch, Alfred C Feller, Niklas Gebauer
Clonal evolution and blastic plasmacytoid dendritic cell neoplasm: malignancies of divergent hematopoietic lineages emerging from a common founding clone. Leukemia 38 (8) (2024)
Amelie Jaeger, Sudheer Madan Mohan Gambheer, Xiaoyang Sun, Dmitry Chernyakov, Oleksandra Skorobohatko, Thomas M Mack, Sandra Kissel, Dietmar Pfeifer, Robert Zeiser, Paul Fisch, Geoffroy Andrieux, Daniela Bräuer-Hartmann, Marcus Bauer, Susann Schulze, Marie Follo, Melanie Börries, Nikolas von Bubnoff, Christoph Cornelius Miething, Jose Villacorta Hidalgo, Claudius Klein, Thomas Weber, Claudia Wickenhauser, Mascha Binder, Christine Dierks
Activated granulocytes and inflammatory cytokine signaling drive T-cell lymphoma progression and disease symptoms. Blood (2023)
Daria Frank, Pradeep Kumar Patnana, Jan Vorwerk, Lianghao Mao, Lavanya Mokada Gopal, Noelle Jung, Thorben Hennig, Leo Ruhnke, Joris Maximillian Frenz, Maithreyan Kuppusamy, Robert J Autry, Lanying Wei, Kaiyan Sun, Helal Mohammed Mohammed Ahmed, Axel Künstner, Hauke Busch, Heiko Müller, Stephan Hutter, Gregor Hoermann, Longlong Liu, Xiaoqing Xie, Yahya Al-Matary, Subbaiah Chary Nimmagadda, Fiorella Charles Cano, Michael Heuser, Felicitas R Thol, Gudrun Göhring, Doris Steinemann, Jürgen Thomale, Theo Leitner, Anja Fischer, Roland Rad, Christoph Röllig, Heidi Altmann, Desiree Kunadt, Wolfgang E Berdel, Jana Hüve, Felix Neumann, Jürgen Klingauf, Virginie Calderon, Bertram Opalka, Ulrich Dührsen, Frank Rosenbauer, Martin Dugas, Julian Varghese, H Christian H Reinhardt, Nikolas von Bubnoff, Tarik Möröy, Georg Lenz, Aarif M N Batcha, Marianna Giorgi, Murugan Selvam, Eunice S Wang, Shannon K McWeeney, Jeffrey W Tyner, Friedrich Stölzel, Matthias Mann, Ashok Kumar Jayavelu, Cyrus Khandanpour
Germline variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy. Blood (2023)
Henry M Nording, Lasse Baron, Manuela Sauter, Antje Lübken, Elias Rawish, Rebecca D Szepanowski, Jacob von Esebeck, Ying Sun, Hossein Emami, Moritz Meusel, Roza Saraei, Nancy Schanze, Sivahari Prasad Gorantla, Nikolas von Bubnoff, Tobias Geisler, Philipp Von Hundelshausen, Konstantinos Stellos, Jens Marquardt, Christian D Sadik, Jörg Koehl, Daniel Duerschmied, Christoph Kleinschnitz, Harald F Langer
Platelets regulate ischemia-induced revascularization and angiogenesis by secretion of growth factor modulating factors. Blood advances (2023)
Michael Rassner, Silvia Waldeck, Marie Follo, Stefanie Jilg, Ulrike Philipp, Martina Jolic, Julius Wehrle, Philipp J Jost, Christian Peschel, Anna Lena Illert, Justus Duyster, Florian Scherer, Nikolas von Bubnoff
Development of Highly Sensitive Digital Droplet PCR for Detection of cKIT Mutations in Circulating Free DNA That Mediate Resistance to TKI Treatment for Gastrointestinal Stromal Tumor (GIST). International journal of molecular sciences 24 (6) (2023)
Amelie Jaeger, Sudheer Madan Mohan Gambheer, Xiaoyang Sun, Dmitry Chernyakov, Oleksandra Skorobohatko, Thomas M Mack, Sandra Kissel, Dietmar Pfeifer, Robert Zeiser, Paul Fisch, Geoffroy Andrieux, Daniela Bräuer-Hartmann, Marcus Bauer, Susann Schulze, Marie Follo, Melanie Börries, Nikolas von Bubnoff, Christoph Cornelius Miething, Jose Villacorta Hidalgo, Claudius Klein, Thomas Weber, Claudia Wickenhauser, Mascha Binder, Christine Dierks
Activated granulocytes and inflammatory cytokine signaling drive T-cell lymphoma progression and disease symptoms. Blood (2023)
Michael Rassner, Silvia Waldeck, Marie Follo, Stefanie Jilg, Ulrike Philipp, Martina Jolic, Julius Wehrle, Philipp J Jost, Christian Peschel, Anna Lena Illert, Justus Duyster, Florian Scherer, Nikolas von Bubnoff
Development of Highly Sensitive Digital Droplet PCR for Detection of cKIT Mutations in Circulating Free DNA That Mediate Resistance to TKI Treatment for Gastrointestinal Stromal Tumor (GIST). International journal of molecular sciences 24 (6) (2023)
Gérard Socie, Dietger Niederwieser, Nikolas von Bubnoff, Mohamad Mohty, Jeffrey Szer, Reuven Or, James Garrett, Anirudh Cadapa Prahallad, Celine Wilke, Robert Zeiser
Prognostic Value of Blood Biomarkers in Steroid-Refractory/Dependent Acute Graft-vs-Host Disease: A REACH2 Analysis. Blood (2023)
Michael Rassner, Silvia Waldeck, Marie Follo, Stefanie Jilg, Ulrike Philipp, Martina Jolic, Julius Wehrle, Philipp J Jost, Christian Peschel, Anna Lena Illert, Justus Duyster, Florian Scherer, Nikolas von Bubnoff
Development of Highly Sensitive Digital Droplet PCR for Detection of cKIT Mutations in Circulating Free DNA That Mediate Resistance to TKI Treatment for Gastrointestinal Stromal Tumor (GIST). International journal of molecular sciences 24 (6) (2023)
Niklas Gebauer, Hanno M Witte, Hartmut Merz, Ilske Oschlies, Wolfram Klapper, Almuth Caliebe, Lars Tharun, Malte Spielmann, Nikolas von Bubnoff, Alfred C Feller, Eva M Murga Penas
Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma. Blood advances 5 (23) (2022)
Axel Künstner, Julian Schwarting, Hanno M Witte, Veronica Bernard, Stephanie Stölting, Kathrin Kusch, Kumar Nagarathinam, Nikolas von Bubnoff, Eva Maria Murga Penas, Hartmut Merz, Hauke Busch, Alfred C Feller, Niklas Gebauer
Integrative molecular profiling identifies two molecularly and clinically distinct subtypes of blastic plasmacytoid dendritic cell neoplasm. Blood cancer journal 12 (7) (2022)
Niklas Gebauer, Maria Ziehm, Judith Gebauer, Armin Riecke, Sebastian Meyhöfer, Birte Kulemann, Nikolas von Bubnoff, Konrad Steinestel, Arthur Bauer, Hanno M Witte
The Glasgow Prognostic Score Predicts Survival Outcomes in Neuroendocrine Neoplasms of the Gastro-Entero-Pancreatic (GEP-NEN) System. Cancers 14 (21) (2022)
Anne Charlet, Max Kappenstein, Philip Keye, Kathrin Kläsener, Cornelia Endres, Teresa Poggio, Sivahari P Gorantla, Stefanie Kreutmair, Jana Sänger, Anna L Illert, Christoph Cornelius Miething, Michael Reth, Justus Duyster, Christoph Rummelt, Nikolas von Bubnoff
The IL-3, IL-5, and GM-CSF common receptor beta chain mediates oncogenic activity of FLT3-ITD-positive AML. Leukemia (2021)
Hanno M Witte, Axel Künstner, Nadine Hertel, Heinz-Wolfram Bernd, Veronica Bernard, Stephanie Stölting, Hartmut Merz, Nikolas von Bubnoff, Hauke Busch, Alfred C Feller, Niklas Gebauer
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways. Blood advances (2021)
Franziska Schlenker, Elena Kipf, Max Deuter, Inga Höffkes, Michael Lehnert, Roland Zengerle, Felix von Stetten, Florian Scherer, Julius Wehrle, Nikolas von Bubnoff, Peter Juelg, Tobias Hutzenlaub, Nadine Borst
Stringent Base Specific and Optimization-Free Multiplex Mediator Probe ddPCR for the Quantification of Point Mutations in Circulating Tumor DNA. Cancers 13 (22) (2021)
Carolin Czauderna, Kim Luley, Nikolas von Bubnoff, Jens U Marquardt
Tailored Systemic Therapy for Colorectal Cancer Liver Metastases. International journal of molecular sciences 22 (21) (2021)
Niklas Gebauer, Axel Künstner, Julius Ketzer, Hanno M Witte, Tobias Rausch, Vladimir Benes, Jürgen Zimmermann, Judith Gebauer, Hartmut Merz, Veronica Bernard, Lana Harder, Katharina Ratjen, Stefan Gesk, Wolfgang Peter, Yannik Busch, Peter Trojok, Nikolas von Bubnoff, Harald Biersack, Hauke Busch, Alfred C Feller
Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing. Blood cancer journal 11 (5) (2021)
Vito Olschewski, Hanno M Witte, Veronica Bernard, Konrad Steinestel, Wolfgang Peter, Hartmut Merz, Johannes Rieken, Harald Biersack, Nikolas von Bubnoff, Alfred C Feller, Niklas Gebauer
Systemic Inflammation and Tumour-Infiltrating T-Cell Receptor Repertoire Diversity Are Predictive of Clinical Outcome in High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements. Cancers 13 (4) (2021)
Alessandro Rambaldi, Alessandra Iurlo, Alessandro Maria Maria Vannucchi, Bruno Martino, Attilio Guarini, Marco Ruggeri, Nikolas von Bubnoff, Marianna De Muro, Mary Frances Frances McMullin, Stefania Luciani, Vincenzo Martinelli, Axel Nogai, Vittorio Rosti, Alessandra Ricco, Paolo Bettica, Sara Manzoni, Silvia Di Tollo
Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program. Blood cancer journal 11 (3) (2021)
Hanno M Witte, Nadine Hertel, Hartmut Merz, Heinz-Wolfram Bernd, Veronica Bernard, Stephanie Stölting, Nikolas von Bubnoff, Alfred C Feller, Niklas Gebauer
Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients. Blood cancer journal 10 (5) (2020)
Jakub Trizuljak, Wolfgang R Sperr, Lucie Nekvindová, Joanne N G Oude Elberink, Karoline V Gleixner, Aleksandra Gorska, Magdalena Lange, Karin Hartmann, Anja Illerhaus, Massimiliano Bonifacio, Cecelia Perkins, Chiara Elena, Luca Malcovati, Anna Belloni Fortina, Khalid Shoumariyeh, Mohamad Jawhar, Roberta Zanotti, Patrizia Bonadonna, Francesca Caroppo, Alexander Zink, Massimo Triggiani, Roberta Parente, Nikolas von Bubnoff, Akif Selim Yavuz, Hans Hägglund, Mattias Mattsson, Jens Peter Panse, Nadja Jäkel, Alex Kilbertus, Olivier Hermine, Michel Arock, David Fuchs, Vito Sabato, Knut Brockow, Agnes Bretterklieber, Marek Niedoszytko, Björn van Anrooij, Andreas Reiter, Jason Gotlib, Hanneke C Kluin-Nelemans, Jiří Mayer, Michael Doubek, Peter Valent
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification. Allergy 75 (8) (2020)
Hanno M Witte, Bastian Bonorden, Armin Riecke, Harald Biersack, Konrad Steinestel, Hartmut Merz, Alfred C Feller, Veronica Bernard, Sebastian Fetscher, Nikolas von Bubnoff, Niklas Gebauer
The Glasgow Prognostic Score at Diagnosis Is a Predictor of Clinical Outcome in Patients with Multiple Myeloma Undergoing Autologous Haematopoietic Stem Cell Transplantation. Cancers 12 (4) (2020)
Miguel Waterhouse, Sandra Pennisi, Dietmar Pfeifer, Max Deuter, Nikolas von Bubnoff, Florian Scherer, Tim Strüssmann, Claudia Wehr, Justus Duyster, Hartmut Bertz, Jürgen Finke, Jesus Duque-Afonso
Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease. Bone marrow transplantation 56 (2) (2020)
Silvia Waldeck, Michael Rassner, Philip Keye, Marie Follo, Dieter Herchenbach, Cornelia Endres, Anne Charlet, Geoffroy Andrieux, Ulrich Salzer, Melanie Boerries, Justus Duyster, Nikolas von Bubnoff
CCL5 mediates target-kinase independent resistance to FLT3 inhibitors in FLT3-ITD-positive AML. Molecular oncology 14 (4) (2020)
Christoph Rummelt, Sivahari P Gorantla, Manja Meggendorfer, Anne Charlet, Cornelia Endres, Konstanze Döhner, Florian H Heidel, Thomas Fischer, Torsten Haferlach, Justus Duyster, Nikolas von Bubnoff
Activating JAK-mutations confer resistance to FLT3 kinase inhibitors in FLT3-ITD positive AML in vitro and in vivo. Leukemia 35 (7) (2020)
Stefanie Jilg, Michael Rassner, Jacqueline Maier, Silvia Waldeck, Victoria Kehl, Marie Follo, Ulrike Philipp, Andreas Sauter, Katja Specht, Jan Mitschke, Thoralf Lange, Sebastian Bauer, Philipp J Jost, Christian Peschel, Justus Duyster, Timo Gaiser, Peter Hohenberger, Nikolas von Bubnoff
Circulating cKIT and PDGFRA DNA indicates disease activity in Gastrointestinal Stromal Tumor (GIST). International journal of cancer 145 (8) (2019)
Jonas Leichsenring, Peter Horak, Simon Kreutzfeldt, Christoph Heining, Petros Christopoulos, Anna-Lena Volckmar, Olaf Neumann, Martina Kirchner, Carolin Ploeger, Jan Budczies, Christoph E Heilig, Barbara Hutter, Martina Fröhlich, Sebastian Uhrig, Daniel N Kazdal, Michael Allgäuer, Alexander Harms, Eugen Rempel, Ulrich Lehmann, Michael Thomas, Nicole Pfarr, Ninel Azoitei, Irina Bonzheim, Ralf Marienfeld, Peter Möller, Martin Werner, Falko Fend, Melanie Boerries, Nikolas von Bubnoff, Silke Lassmann, Thomas Longerich, Michael Bitzer, Thomas Seufferlein, Nisar Malek, Wilko Weichert, Peter Schirmacher, Roland Penzel, Volker Endris, Benedikt Brors, Frederick Klauschen, Hanno Glimm, Stefan Fröhling, Albrecht Stenzinger
Variant classification in precision oncology. International journal of cancer 145 (11) (2019)
Alessandro Prestipino, Alica J Emhardt, Konrad Aumann, David O'Sullivan, Sivahari P Gorantla, Sandra Duquesne, Wolfgang Melchinger, Lukas M Braun, Slavica Vuckovic, Melanie Boerries, Hauke Busch, Sebastian Halbach, Sandra Pennisi, Teresa Poggio, Petya Apostolova, Pia Veratti, Michael Hettich, Gabriele Niedermann, Mark D Bartholomä, Khalid Shoumariyeh, Jonas Samuel Jutzi, Julius Wehrle, Christine Dierks, Heiko Becker, Annette Schmitt-Graeff, Marie Follo, Dietmar Pfeifer, Jan C Rohr, Sebastian Fuchs, Stephan Ehl, Frederike A Hartl, Susana Minguet, Christoph Cornelius Miething, Florian H Heidel, Nicolaus M Kröger, Ioanna Triviai, Tilman Brummer, Jürgen Finke, Anna L Illert, Eliana Ruggiero, Chiara Bonini, Justus Duyster, Heike Luise Pahl, Steven W Lane, Geoffrey R Hill, Bruce R Blazar, Nikolas von Bubnoff, Erika L Pearce, Robert Zeiser
Oncogenic JAK2V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms. Science translational medicine 10 (429) (2019)
Nikolas von Bubnoff, Gabriele Ihorst, Olga Grishina, Nadine Röthling, Hartmut Bertz, Justus Duyster, Jürgen Finke, Robert Zeiser
Ruxolitinib in GvHD (RIG) study: a multicenter, randomized phase 2 trial to determine the response rate of Ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628). BMC cancer 18 (1) (2018)